Alterations in Body Fat and Composition among Thai Transgender Men Undergoing Short-term Testosterone Therapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20241004001

Enrollment

Registered

2024-10-04

Start date

2022-09-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body composition changes after testosterone therapy in Transmen Trans men Gender-affirming hormone therapy Testosterone Fat mass Dual-energy X-ray absorptiometry

Interventions

Testosterone-naive transmasculine individuals plan for testosterone therapy

Basic Science

Testosterone-naive transmasculine individuals

Eligibility

Sex/Gender

Female

Age

20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Testosterone-naive transmasculine individuals

Exclusion criteria

Exclusion criteria: 1. retroviral infection 2. psychotic disorders 3. medications interfering with testosterone metabolism 4. abnormalities in renal or hepatic function

Design outcomes

Primary

Measure	Time frame
Fat mass at baseline and 6 months after treatment Whole-body DXA scan	—

Secondary

Measure	Time frame
Lean mass at baseline and 6 months after treatment Whole-body DXA scan,Laboratory parameters and sex hormone at baseline, 3 and 6 months after treatment Blood test	—

Countries

Thailand

Contacts

Public ContactPanachai Nimitpanya

Faculty of Medicine, Chulalongkorn University

phonepanachai@docchula.com022564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026